Man Group PLC Wave Life Sciences Ltd. Transaction History

Man Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.58 - $6.3 $54,584 - $96,056	15,247 Added 85.46%	33,089 $143,000
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $56,737 - $124,894	17,842 New	17,842 $124,000
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $64,494 - $85,270	-11,415 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $424,677 - $909,157	-75,700 Reduced 86.9%	11,415 $64,000
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $608,933 - $806,684	87,115 New	87,115 $686,000
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $213,250 - $288,032	-5,748 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $208,939 - $317,289	5,748 New	5,748 $287,000
Q2 2018 Aug 14, 2018	SELL	$33.85 - $50.65 $184,753 - $276,447	-5,458 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $177,112 - $298,552	5,458 New	5,458 $219,000

192

122M

430K

330K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $840M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.